Gain Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 676.82 K | $1.21 M | -0.01% | 2.23% |
| DME CAPITAL MANAGEMENT, LP | 11/14/2025 | 566.13 K | $1.00 M | 0.00% | 1.87% |
| VANGUARD GROUP INC | 11/07/2025 | 534.35 K | $945.80 K | 0.00% | 1.76% |
| CITADEL ADVISORS LLC | 11/14/2025 | 373.56 K | $661.20 K | 130.85% | 1.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 344.15 K | $609.19 K | 18.48% | 1.13% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 11/12/2025 | 318.65 K | $564.00 K | 77.52% | 1.05% |
| MARSHALL WACE, LLP | 11/13/2025 | 175.11 K | $309.94 K | -36.65% | 0.58% |
| MORGAN STANLEY | 11/14/2025 | 155.68 K | $275.55 K | 103.46% | 0.51% |
| UBS GROUP AG | 11/13/2025 | 140.68 K | $249.00 K | 331.06% | 0.46% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 126.10 K | $223.20 K | 34.15% | 0.42% |
| BLACKROCK, INC. | 11/12/2025 | 116.18 K | $205.65 K | 3.27% | 0.38% |
| STATE STREET CORP | 11/14/2025 | 91.14 K | $161.31 K | 28.11% | 0.30% |
| NORTHERN TRUST CORP | 11/14/2025 | 88.40 K | $156.47 K | -11.75% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 80.44 K | $142.37 K | 1.11% | 0.27% |
| JANE STREET GROUP, LLC | 11/14/2025 | 72.45 K | $128.24 K | 100.00% | 0.24% |
| XTX TOPCO LTD | 11/14/2025 | 54.20 K | $95.94 K | 100.00% | 0.18% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 54.01 K | $96.00 K | 126.91% | 0.18% |
| KOVITZ INVESTMENT GROUP PARTNERS, LLC | 11/10/2025 | 47.58 K | $84.21 K | 0.00% | 0.16% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 38.54 K | $68.21 K | 100.00% | 0.13% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2025 | 35.82 K | $63.40 K | 0.00% | 0.12% |
| BENEDICT FINANCIAL ADVISORS INC | 11/03/2025 | 35.00 K | $61.95 K | 55.56% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 30.00 K | $53.11 K | 0.00% | 0.10% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 27.32 K | $48.36 K | 100.00% | 0.09% |
| JPMORGAN CHASE & CO | 11/26/2025 | 26.28 K | $46.52 K | 100.00% | 0.09% |
| HRT FINANCIAL LP | 11/14/2025 | 19.72 K | $34.00 K | 100.00% | 0.07% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 16.78 K | $29.69 K | 162.07% | 0.06% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/29/2025 | 15.56 K | $31.42 K | 100.00% | 0.05% |
| SANDHILL CAPITAL PARTNERS LLC | 11/13/2025 | 15.40 K | $27.26 K | 0.00% | 0.05% |
| KESTRA ADVISORY SERVICES, LLC | 11/14/2025 | 12.00 K | $21.24 K | 100.00% | 0.04% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 11.57 K | $20.49 K | 100.00% | 0.04% |
| BISON WEALTH, LLC | 11/12/2025 | 10.75 K | $19.78 K | 0.00% | 0.04% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 10.60 K | $18.76 K | 0.00% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2025 | 10.30 K | $18.23 K | 100.00% | 0.03% |
| CREEKMUR ASSET MANAGEMENT LLC | 11/12/2025 | 4.44 K | $7.86 K | 0.00% | 0.01% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 4.41 K | $7.81 K | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 3.91 K | $6.92 K | -6.17% | 0.01% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 3.25 K | $5.75 K | 30.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 2.65 K | $4.69 K | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 2.06 K | $3.65 K | 118.41% | 0.01% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| GOTHAM ASSET MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE OF WYOMING | 11/04/2025 | 0 | $0 | -100.00% | 0.00% |
| DAUNTLESS INVESTMENT GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gain Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 47 institutional investors and hedge funds held shares of Gain Therapeutics, Inc.. The most heavily invested institutionals were:
JONES FINANCIAL COMPANIES LLLP: 676,822
DME Capital Management, LP: 566,130
VANGUARD GROUP INC: 534,352
CITADEL ADVISORS LLC: 373,558
GEODE CAPITAL MANAGEMENT, LLC: 344,146
Cambridge Investment Research Advisors, Inc.: 318,645
14.31% of Gain Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.14 M shares in the last 24 months. This purchase volume represents approximately $9.86 M in transactions.